CellaVision expands the utility of the CellaVision DM96 digital morphology system

Two new products to be launched at the Medica Exhibition in
Düsseldorf on 14th of November

CellaVision, which develops and sells digital morphology products for
the routine analysis of blood, widens its product offering to
clinical laboratories by launching a new application for the analysis
of body fluids, including cerebrospinal, synovial and pleural fluids.
In addition, a new version of the blood application will be launched,
now offering a way to digitize an entire slide."We see a great demand amongst our clients for the type of  functions
that CellaVision can now offer. To be able to analyze blood and other
body fluids in a safe, efficient,  and comfortable way is surely  the
ideal solution for many laboratories," says Yvonne Mårtensson, CEO of
CellaVision. "The  ability  to  scan full  slides  is  an  additional
service offered to laboratories which will give us an opportunity  to
further evaluate the market needs in other imaging segments, such  as
Pathology and Cytology."

Using   CellaVision's   application   for   body   fluids,   clinical
laboratories are  now able  to  analyze and  assess cells  in  spinal
fluid, synovial fluid, and pleural  fluid. The advantages of the  new
application are  the  same as  those  for  blood -  faster  and  more
standardized results,  digital  archiving of  samples  together  with
patient records, as well  as sharing of  digital images with  experts
outside the laboratory.

A  new  function  has   been  added  to   software  version  2.0   of
CellaVision's application  for peripheral  blood which  makes it  now
possible to capture  digital images  of any desired  area of  slides,
creating a Digital Slide. Although primarily designed for  Hematology
smears, the digitalization function is also applicable to other types
of specimens, for educational purposes. It gives a useful overview of
the sample and allows for discussion between physicians regardless of
physical location.

CellaVision will present the new products  at the Medica, one of  the
world's  largest  medical  technology  conventions,  in   Düsseldorf,
Germany, between  the 14th  and 17th  of November.  CellaVision  will
display its products in HALL 1, booth A32. The company's distributor,
Sysmex, will also display the products.

The application for body fluids will be offered as a separate product
while the function for digital scanning of samples is included in the
company's most  recent software  version for  peripheral blood.  Both
functions are  available for  the CellaVision(TM)  DM96 analyzer  and
will be commercially available in Europe in the beginning of 2008. An
application to  the Food  and  Drug Administration  (FDA)  concerning
sales of the body fluids application  in the US will be submitted  at
the same time.

For more information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 286 44 00. E-mail: yvonne.martensson@cellavision.com

About CellaVision
CellaVision AB develops, markets, and sells market-leading systems
for performing automatic identification of white blood cells,
characterization of red blood cell morphology, and software for
education and competency assessment. The company's core competencies
are in advanced imaging analysis, artificial intelligence, and
automated microscopy, resulting in the development of software and
hardware for automatic image analysis of cells and cell changes, with
applications in healthcare.

The company headquarters are in Lund, Sweden and has subsidiaries in
Jupiter, FL, USA, and Toronto, ON, Canada. For more information,
visit www.cellavision.com.

CellaVision's share is listed on First North at the OMX Stockholm
Stock Exchange. The company's Certified Advisor is Remium AB.